MZE829 Clinical Trials (2026): 1 Studies for Proteinuric Kidney Disease

Hipa.ai Research · Source: ClinicalTrials.gov / AACT

Synced daily from ClinicalTrials.gov via AACT. Last sync: .

1 MZE829 clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 1 indication (including Proteinuric Kidney Disease) and 56 total planned enrollment. 1 MZE829 clinical trial is actively recruiting at 72 U.S. sites across 23 states. Most recent activity: NCT06830629 (Sep 2026).

Where to Participate: All MZE829 Trial Sites in the U.S. (72 sites across 23 states)

Every actively recruiting MZE829trial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.

StateFacilityCityTrialMap
ALResearch SiteDecatur35601NCT06830629Map
ALResearch SiteHuntsville35805NCT06830629Map
ALResearch SiteMontgomery36106NCT06830629Map
ALResearch SiteMontgomery36117NCT06830629Map
CAResearch SiteGranada Hills91344NCT06830629Map
CTResearch SiteBloomfield06112NCT06830629Map
FLResearch SiteAtlantis33462NCT06830629Map
FLResearch SiteBrandon33511NCT06830629Map
FLResearch SiteBrooksville34613NCT06830629Map
FLResearch SiteHollywood33024NCT06830629Map
FLResearch SiteMelbourne32901NCT06830629Map
FLResearch SiteMiami Lakes33014NCT06830629Map
FLResearch SiteOrlando32822NCT06830629Map
GAResearch SiteAtlanta30309NCT06830629Map
GAResearch SiteCollege Park30349NCT06830629Map
GAResearch SiteCordele31015NCT06830629Map
GAResearch SiteLithia Springs30122NCT06830629Map
GAResearch SiteMacon31210NCT06830629Map
GAResearch SiteRiverdale30274NCT06830629Map
GAResearch SiteRiverdale30296NCT06830629Map
GAResearch SiteSavannah31406NCT06830629Map
GAResearch SiteSnellville30078NCT06830629Map
ILResearch SiteChicago60616NCT06830629Map
ILResearch SiteChicago60643NCT06830629Map
KSResearch SiteKansas City66112NCT06830629Map
KYResearch SiteBowling Green42101NCT06830629Map
KYResearch SiteLouisville40205NCT06830629Map
MDResearch SiteArnold21012NCT06830629Map
MDResearch SiteLutherville21093NCT06830629Map
MDResearch SiteOxon Hill20745NCT06830629Map
MIResearch SiteDearborn48126NCT06830629Map
MIResearch SiteFlint48503NCT06830629Map
MIResearch SitePontiac48341NCT06830629Map
MIResearch SiteSaint Joseph49085NCT06830629Map
MIResearch SiteShelby48092NCT06830629Map
MNResearch SiteMinneapolis55404NCT06830629Map
MSResearch SiteTupelo38801NCT06830629Map
MOResearch SiteCity of Saint Peters63376NCT06830629Map
MOResearch SiteSt Louis63103NCT06830629Map
NVResearch SiteLas Vegas89107NCT06830629Map
NYResearch SiteBuffalo14203NCT06830629Map
NYResearch SiteLaurelton11413NCT06830629Map
NYResearch SiteMaspeth11378NCT06830629Map
NYResearch SiteNew York10021NCT06830629Map
NYResearch SiteNewburgh12550NCT06830629Map
NCResearch SiteDurham27708NCT06830629Map
NCResearch SiteFayetteville28304NCT06830629Map
NCResearch SiteGreensboro27405NCT06830629Map
NCResearch SiteShelby28150NCT06830629Map
OHResearch SiteCincinnati45267NCT06830629Map
OHResearch SiteCleveland44106NCT06830629Map
OHResearch SiteCleveland44195NCT06830629Map
OHResearch SiteColumbus43215NCT06830629Map
OKResearch SiteArdmore73401NCT06830629Map
PAResearch SitePhiladelphia19104NCT06830629Map
PAResearch SitePhiladelphia19107NCT06830629Map
PAResearch SiteUpland19013NCT06830629Map
SCResearch SiteColumbia29203NCT06830629Map
SCResearch SiteSpartanburg29302NCT06830629Map
SCResearch SiteSpartanburg29306NCT06830629Map
TNResearch SiteChattanooga37404NCT06830629Map
TXResearch SiteDallas75230NCT06830629Map
TXResearch SiteDallas75246NCT06830629Map
TXResearch SiteGreenville75402NCT06830629Map
TXResearch SiteHouston77030NCT06830629Map
TXResearch SiteHouston77054NCT06830629Map
TXResearch SiteHouston77099NCT06830629Map
TXResearch SiteMcKinney75069NCT06830629Map
TXResearch SiteSan Antonio78251NCT06830629Map
TXResearch SiteShenandoah77384NCT06830629Map
TXResearch SiteSherman75092NCT06830629Map
VAResearch SiteNorfolk23504NCT06830629Map

MZE829 clinical trials at a glance: phase × recruitment status

PhaserecruitingTotal
P211

Recruiting MZE829 clinical trials (1)

Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).

NCT IDTitlePhaseIndicationEnrollmentStarted
NCT06830629A Phase 2 Study of MZE829 in Adults With APOL1 Kidney DiseaseP2Proteinuric Kidney Disease56Feb 2025

All MZE829 trials (1)

Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.

NCT IDAcronymTitlePhaseStatusEnrollmentSponsorStarted
NCT06830629A Phase 2 Study of MZE829 in Adults With APOL1 Kidney DiseaseP2recruiting56Maze TherapeuticsFeb 2025

MZE829 clinical trials: frequently asked questions

How many MZE829 clinical trials are there?
1 MZE829 clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 1 is actively recruiting participants.
Are MZE829 clinical trials recruiting in 2026?
Yes — 1 MZE829 trial is actively recruiting in 2026, with 72 U.S. sites across 23 states. See the recruiting trials and the per-state site list further down this page.
What conditions is MZE829 being studied for?
MZE829 is being studied for Proteinuric Kidney Disease. The trials are grouped by indication on this page.
What phase is MZE829 in?
MZE829 clinical trials span 1 Phase 2. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
Who sponsors MZE829 clinical trials?
The lead sponsor across the most MZE829 trials is Maze Therapeutics. Each trial row links to the full study detail page including sponsor information.

Sources and methodology

Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming MZE829as an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.

Last refreshed .

Related pages on Hipa.ai:

MZE829 overview